Results 201 to 210 of about 183,487 (307)
Plasticity in the structure and assembly of proteasomes. [PDF]
Chang AH, Sengupta S, Tomko RJ.
europepmc +1 more source
ABSTRACT Cisplatin resistance remains a major obstacle in the treatment of gastric cancer (GC), and autophagy has been increasingly recognized as a key cytoprotective mechanism contributing to chemoresistance. CREB3L4 is an endoplasmic reticulum membrane‐bound transcription factor that has been shown to regulate the expression of Bcl‐2 associated ...
Wen‐Ke Yin +3 more
wiley +1 more source
A de novo H3.2K9me2 deposition pathway establishes heterochromatin for suppressing transposon mobilization during fly somatic development. [PDF]
Luo YN +5 more
europepmc +1 more source
Mass Spectrometry Structural Proteomics Enabled by Limited Proteolysis and Cross‐Linking
ABSTRACT The exploration of protein structure and function stands at the forefront of life science and represents an ever‐expanding focus in the development of proteomics. As mass spectrometry (MS) offers readout of protein conformational changes at both the protein and peptide levels, MS‐based structural proteomics is making significant strides in the
Haiyan Lu +4 more
wiley +1 more source
A widespread protein misfolding mechanism is differentially rescued in vitro by chaperones based on gene essentiality. [PDF]
Sitarik I +5 more
europepmc +1 more source
ABSTRACT Anaplastic thyroid cancer (ATC) is the most aggressive form of thyroid cancer. Despite recent advances in treating BRAFV600E‐driven ATC, therapy resistance remains a significant challenge, often resulting in disease progression and death.
Shawn Noronha +26 more
wiley +1 more source
A J-domain protein enhances memory by promoting physiological amyloid formation in <i>Drosophila</i>. [PDF]
Patton K +7 more
europepmc +1 more source
Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks [PDF]
Bengoechea, Rocio, Weihl, Conrad C.
core +1 more source
Abstract Background Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine (polyQ) neurogenerative disorder that results from CAG trinucleotide repeat expansions in the ATXN3 gene, leading to toxic protein aggregate formation and cellular pathway dysfunction.
Tiago Moreira‐Gomes +9 more
wiley +1 more source

